Claret Asset Management’s Takeda Pharmaceutical TAK Stock Holding History

Claret Asset Management’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-10,150	Closed	-$154K	–	176
2020 Q1	$154K	Sell	10,150 -1,329	-12%	-$24.1K	0.04%	152
2019 Q4	$226K	Sell	11,479 -3,123	-21%	-$59.7K	0.04%	171
2019 Q3	$251K	Sell	14,602 -1,982	-12%	-$34.3K	0.05%	160
2019 Q2	$294K	Sell	16,584 -3,383	-17%	-$61.6K	0.06%	153
2019 Q1	$407K	Buy	+19,967	New	+$402K	0.08%	127

Other funds holding TAK

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Adelphi Capital London, United Kingdom $3.21M AUM 121.6% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Claret Asset Management's TAK Position: Q2 2020 in Review

Claret Asset Management sold out of Takeda Pharmaceutical (TAK) in Q2 2020, closing a stake of 10,150 shares — an estimated $154K sold.

Claret Asset Management first reported a position in TAK in Q1 2019 and held it in 5 quarters. The position peaked at $407K in Q1 2019. 308 funds tracked by Wall St. Rank hold TAK as of Q2 2020.

Claret Asset Management reported no remaining Takeda Pharmaceutical position as of Q2 2020 after selling out during the quarter.
Claret Asset Management sold 10,150 Takeda Pharmaceutical shares in Q2 2020, an estimated $154K.
Claret Asset Management first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 5 quarters.
Claret Asset Management's Takeda Pharmaceutical position peaked at $407K in Q1 2019.
308 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2020.

Based on Claret Asset Management's 13F filing for Q2 2020, filed 6 Aug 2020.